Sphingomyelin synthase–related protein SMSr is a phosphatidylethanolamine phospholipase C that promotes nonalcoholic fatty liver disease
Journal of Biological Chemistry · 2023
DOI: 10.1016/j.jbc.2023.105162 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Yeun-Po Chiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, SUNY Downstate Health Sciences University, Brooklyn, New York, USA. Hauptthemen laut MEDLINE: Neoplasms, Non-alcoholic Fatty Liver Disease, Transferases (Other Substituted Phosphate Groups). Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIA NIH HHS, BLRD VA.
Abstract (Originalsprache)
Sphingomyelin synthase (SMS)-related protein (SMSr) is a phosphatidylethanolamine phospholipase C (PE-PLC) that is conserved and ubiquitous in mammals. However, its biological function is still not clear. We previously observed that SMS1 deficiency-mediated glucosylceramide accumulation caused nonalcoholic fatty liver diseases (NAFLD), including nonalcoholic steatohepatitis (NASH) and liver fibrosis. Here, first, we evaluated high-fat diet/fructose-induced NAFLD in Smsr KO and WT mice. Second, we evaluated whether SMSr deficiency can reverse SMS1 deficiency-mediated NAFLD, using Sms1/Sms2 double and Sms1/Sms2/Smsr triple KO mice. We found that SMSr/PE-PLC deficiency attenuated high-fat diet/fructose-induced fatty liver and NASH, and attenuated glucosylceramide accumulation-induced NASH, fibrosis, and tumor formation. Further, we found that SMSr/PE-PLC deficiency reduced the expression of many inflammatory cytokines and fibrosis-related factors, and PE supplementation in vitro or in vivo mimicked the condition of SMSr/PE-PLC deficiency. Furthermore, we demonstrated that SMSr/PE-PLC deficiency or PE supplementation effectively prevented membrane-bound β-catenin transfer to the nucleus, thereby preventing tumor-related gene expression. Finally, we observed that patients with NASH had higher SMSr protein levels in the liver, lower plasma PE levels, and lower plasma PE/phosphatidylcholine ratios, and that human plasma PE levels are negatively associated with tumor necrosis factor-α and transforming growth factor β1 levels. In conclusion, SMSr/PE-PLC deficiency causes PE accumulation, which can attenuate fatty liver, NASH, and fibrosis. These results suggest that SMSr/PE-PLC inhibition therapy may mitigate NAFLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, SUNY Downstate Health Sciences University, Brooklyn, New York, USA.
- Lipidomics Core, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
- Department of Cell Biology, SUNY Downstate Health Sciences University, Brooklyn, New York, USA; Molecular and Cellular Cardiology Program, VA New York Harbor Healthcare System, Brooklyn, New York, USA. Electronic addres…
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
- BLRD VA
- US Department of Veterans Affairs
- National Institutes of Health
Zitieren
APA
Chiang, Y. P., Li, Z., He, M., Jones, Q., Pan, M., Han, X., & Jiang, X. C. (2023). Sphingomyelin synthase–related protein SMSr is a phosphatidylethanolamine phospholipase C that promotes nonalcoholic fatty liver disease. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105162
Vancouver
Chiang YP, Li Z, He M, Jones Q, Pan M, Han X, et al. Sphingomyelin synthase–related protein SMSr is a phosphatidylethanolamine phospholipase C that promotes nonalcoholic fatty liver disease. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.105162
BibTeX
@article{Chiang2023,
author = {Chiang, Yeun-Po and Li, Zhiqiang and He, Mulin and Jones, Quiana and Pan, Meixia and Han, Xianlin and Jiang, Xian-Cheng},
title = {Sphingomyelin synthase–related protein SMSr is a phosphatidylethanolamine phospholipase C that promotes nonalcoholic fatty liver disease},
journal = {Journal of Biological Chemistry},
year = {2023},
doi = {10.1016/j.jbc.2023.105162}
}
EUVIMED